Impact of cigarette smoking on extent of coronary artery disease and prognosis of patients with non-ST-segment elevation acute coronary syndromes: An analysis from the ACUITY trial (acute catheterization and urgent intervention triage strategy)

JACC: Cardiovascular Interventions

Volumn 7, Issue 4, 2014, Pages 372-379

  Robertson, Jason O ^a   Ebrahimi, Ramin ^b   Lansky, Alexandra J ^c   Mehran, Roxana ^d,e   Stone, Gregg W ^e,f   Lincoff, A Michael ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^f Department of Medicine   (United States)

Author keywords

ACUITY; non ST segment elevation acute coronary syndrome; smoker; smoker's paradox

Indexed keywords

AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLEEDING; CONTROLLED STUDY; CORE LABORATORY; CORONARY ARTERY DISEASE; FEMALE; FOLLOW UP; HEART MUSCLE REVASCULARIZATION; HIGH RISK PATIENT; HUMAN; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION ACUTE CORONARY SYNDROME; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SMOKING; ACUTE CORONARY SYNDROME; CHI SQUARE DISTRIBUTION; COMORBIDITY; EMERGENCY HEALTH SERVICE; HEMORRHAGE; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK; RISK ASSESSMENT; RISK FACTOR; SEVERITY OF ILLNESS INDEX; TIME; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; AGED; CHI-SQUARE DISTRIBUTION; COMORBIDITY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; HEMORRHAGE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; ODDS RATIO; PERCUTANEOUS CORONARY INTERVENTION; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SMOKING; TIME FACTORS; TREATMENT OUTCOME; TRIAGE;

EID: 84898785665     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2013.11.017     Document Type: Article

References (37)

1. G. Montalescot, J. Dallongeville, and E. Van Belle et al. STEMI and NSTEMI: are they so different? 1 year outcomes in acute myocardial infarction as defined by the ESC/ACC definition (the OPERA registry) Eur Heart J 28 2007 1409 1417
2. E.M. Antman, M. Hand, and P.W. Armstrong et al. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 51 2008 210 247
3. United States Department of Health and Human Services Reducing the health consequences of smoking: 25 years of progress. A report of the surgeon general 1989 Public Health Office, Center for Disease Control, Office on Smoking and Health. DHHS Publication No. (CDC) 89-8411 Rockville, MD
4. M.M. Rahman, and I. Laher Structural and functional alteration of blood vessels caused by cigarette smoking: an overview of molecular mechanisms Curr Vasc Pharmacol 5 2007 276 292
5. D. Himbert, M. Klutman, G. Steg, K. White, and D.C. Gulba Cigarette smoking and acute coronary syndromes: a multinational observational study Int J Cardiol 100 2005 109 117
6. C.L. Grines, E.J. Topol, and W.W. O'Neill et al. Effect of cigarette smoking on outcome after thrombolytic therapy for myocardial infarction Circulation 91 1995 298 303
7. M. Ishihara, H. Sato, and H. Tateishi et al. Clinical implications of cigarette smoking in acute myocardial infarction: acute angiographic findings and long-term prognosis Am Heart J 134 1997 955 960
8. T.L. Kelly, E. Gilpin, S. Ahnve, H. Henning, and J. Ross Jr. Smoking status at the time of acute myocardial infarction and subsequent prognosis Am Heart J 110 1985 535 541
9. K.L. Lee, L.H. Woodlief, E.J. Topol GUSTO-I Investigators Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results: from an international trial of 41,021 patients Circulation 91 1995 1659 1668
10. C. de Chillou, P. Riff, and N. Sadoul et al. Influence of cigarette smoking on rate of reopening of the infarct-related coronary artery after myocardial infarction: a multivariate analysis J Am Coll Cardiol 27 1996 1662 1668
11. B.G. Angeja, S. Kermgard, and M.S. Chen et al. The smoker's paradox: insights from the angiographic substudies of the TIMI trials J Thromb Thrombolysis 13 2002 133 139
12. G.I. Barbash, J. Reiner, and H.D. White et al. Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the "smoker's paradox" from the GUSTO-I trial, with angiographic insights J Am Coll Cardiol 26 1995 1222 1229
13. N. Bettencourt, P. Mateus, and C. Dias et al. The smoker's - a hemodynamic reality? Rev Port Cardiol 23 2004 547 555
14. J.P. Strong, and M.L. Richards Cigarette smoking and atherosclerosis in autopsied men Atherosclerosis 23 1976 451 476
15. W.S. Weintraub Cigarette smoking as a risk factor for coronary artery disease Adv Exp Med Biol 273 1990 27 37
16. S.J. Nicholls, E.M. Tuzcu, and T. Crowe et al. Relationship between cardiovascular risk factors and atherosclerotic disease burden measured by intravascular ultrasound J Am Coll Cardiol 47 2006 1967 1975
17. G.W. Stone, J.H. Ware, and M.E. Bertrand et al. Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trial JAMA 298 2007 2497 2506
18. J.A. Ambrose, O.D. Almeida, and S.K. Sharma et al. Adjunctive thrombolytic therapy during angioplasty for ischemic rest angina. Results: of the TAUSA Trial Circulation 90 1994 69 77
19. G.W. Stone, M. Bertrand, and A. Colombo et al. Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: study design and rationale Am Heart J 148 2004 764 775
20. E.M. Antman, M. Cohen, and P.J. Bernink et al. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making JAMA 284 2000 835 842
21. T.I.M.I. The Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial - phase I findings N Engl J Med 312 1985 932 936
22. C.M. Gibson, C.P. Cannon, and W.L. Daley et al. TIMI frame count: a quantitative method of assessing coronary artery flow Circulation 93 1996 879 888
23. A.W. van 't Hof, A. Liem, H. Suryapranata, J.C. Hoorntje, M.J. de Boer, and F. Zijlstra Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade Circulation 97 1998 2302 2306
24. G.W. Stone, B.T. McLaurin, and D.A. Cox et al. Bivalirudin for patients with acute coronary syndromes N Engl J Med 355 2006 2203 2216
25. G. Weisz, D.A. Cox, and E. Garcia et al. Impact of smoking status on outcomes of primary coronary intervention for acute myocardial infarction - the smoker's paradox revisited Am Heart J 150 2005 358 364
26. S. Castela, R. Duarte, and R.P. Reis et al. Acute coronary syndromes in smokers: clinical and angiographic characteristics Rev Port Cardiol 23 2004 697 705
27. G.R. Dagenais, Q. Yi, E. Lonn, P. Sleight, J. Ostergren, and S. Yusuf Impact of cigarette smoking in high-risk patients participating in a clinical trial. A substudy from the Heart Outcomes Prevention Evaluation (HOPE) trial Eur J Cardiovasc Prev Rehabil 12 2005 75 81
28. P. Weiner, J. Waizman, M. Weiner, M. Rabner, R. Magadle, and D. Zamir Smoking and first acute myocardial infarction: age, mortality and smoking cessation rate Isr Med Assoc J 2 2000 446 449
29. S.V. Manoukian, F. Feit, and R. Mehran et al. Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY trial J Am Coll Cardiol 49 2007 1362 1368
30. M.T. Roe, A.R. Halabi, and R.H. Mehta et al. Documented traditional cardiovascular risk factors and mortality in non-ST-segment elevation myocardial infarction Am Heart J 153 2007 507 514
31. L. Wexler, B. Brundage, and J. Crouse et al. Coronary artery calcification: pathophysiology, epidemiology, imaging methods, and clinical implications. A statement for health professionals from the American Heart Association Circulation 94 1996 1175 1192
32. E. Falk, P.K. Shah, and V. Fuster Coronary plaque disruption Circulation 92 1995 657 671
33. V. Fuster Lewis A. Conner Memorial Lecture. Mechanisms leading to myocardial infarction: insights from studies of vascular biology Circulation 90 1994 2126 2146
34. M.J. Davies, P.D. Richardson, N. Woolf, D.R. Katz, and J. Mann Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content Br Heart J 69 1993 377 381
35. E. Falk Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis. Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi Br Heart J 50 1983 127 134
36. D. Steinberg Antioxidants and atherosclerosis. A current assessment Circulation 84 1991 1420 1425
37. C. Seiler The human coronary collateral circulation Heart 89 2003 1352 1357